CVALF (Covalon Technologies) FFO


CVALF Covalon Technologies Ltd CVALF
82 GF Score
Price $1.56
GF Value $1.54
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Covalon Technologies FFO?

FFO (Funds from operations) only applies to REITs.

CVALF
82GF Score
Covalon Technologies Ltd CVALF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Covalon Technologies (CVALF) Overvalued in 2026?

Based on GuruFocus' analysis, Covalon Technologies stock appears to be overvalued. The current stock price of $1.56 is trading 1.3% above its estimated GF Value™ of $1.54. GuruFocus considers Covalon Technologies to be Fairly Valued.

Key valuation signals for CVALF:

  • FFO:
  • GF Value™: $1.54 vs. price of $1.56 (1.3% above fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Covalon Technologies Business Description

Other Exchanges COV:Canada
Address 1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
82GF Score

Get the complete analysis for CVALF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.56
Price
$1.54
GF Value